Cargando…

Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional Cure

BACKGROUND & AIMS: To provide an adequate treatment strategy for chronic hepatitis B, it is essential to know which patients are expected to have a good prognosis and which patients do not require therapeutic intervention. Previously, we identified the substitution of isoleucine to leucine at am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honda, Takashi, Yamada, Norie, Murayama, Asako, Shiina, Masaaki, Aly, Hussein Hassan, Kato, Asuka, Ito, Takanori, Ishizu, Yoji, Kuzuya, Teiji, Ishigami, Masatoshi, Murakami, Yoshiki, Tanaka, Tomohisa, Moriishi, Kohji, Nishitsuji, Hironori, Shimotohno, Kunitada, Ishikawa, Tetsuya, Fujishiro, Mitsuhiro, Muramatsu, Masamichi, Wakita, Takaji, Kato, Takanobu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536788/ https://www.ncbi.nlm.nih.gov/pubmed/34352407 http://dx.doi.org/10.1016/j.jcmgh.2021.07.013

Ejemplares similares

Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus
por: Yato, Keigo, et al.
Publicado: (2022)

Hepatitis B Virus Genotype-Dependent Vulnerability of Infected Cells to Immune Reaction in the Early Phase of Infection
por: Shiina, Masaaki, et al.
Publicado: (2019)

Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen
por: Washizaki, Ayaka, et al.
Publicado: (2022)

The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro
por: Gad, Sameh A., et al.
Publicado: (2022)

Completion of the Entire Hepatitis C Virus Life Cycle in Vero Cells Derived from Monkey Kidney
por: Murayama, Asako, et al.
Publicado: (2016)

Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity
por: Yoshioka, Naoki, et al.
Publicado: (2019)

Transient deterioration of albumin–bilirubin scores in early post-dose period of molecular targeted therapies in advanced hepatocellular carcinoma with 50% or higher liver occupation: A STROBE-compliant retrospective observational study
por: Muto, Hisanori, et al.
Publicado: (2021)

Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling
por: Sugiyama, Ryuichi, et al.
Publicado: (2017)

Single Strain Isolation Method for Cell Culture-Adapted Hepatitis C Virus by End-Point Dilution and Infection
por: Sugiyama, Nao, et al.
Publicado: (2014)

Performance Evaluation of In Vitro Screening and Diagnostic Kits for Hepatitis C Virus Infection
por: Murayama, Asako, et al.
Publicado: (2022)

N6-methyladenosine Modification of Hepatitis B Virus RNA in the Coding Region of HBx
por: Murata, Takayuki, et al.
Publicado: (2023)

Limitation of non-transplant treatment and proper timing for liver transplantation in patients with hepatocellular carcinoma considering long-term survival
por: Nomura, Aya, et al.
Publicado: (2020)

Performance evaluation of in vitro diagnostic kits for hepatitis B virus infection using the regional reference panel of Japan
por: Momose, Haruka, et al.
Publicado: (2023)

Changes in the gut microbiota after hepatitis C virus eradication
por: Honda, Takashi, et al.
Publicado: (2021)

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide
por: Miyakawa, Kei, et al.
Publicado: (2018)

Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins
por: Miyakawa, Kei, et al.
Publicado: (2022)

Development and Use of a Kinetical and Real-Time Monitoring System to Analyze the Replication of Hepatitis C Virus
por: Li, Xiaoyu, et al.
Publicado: (2022)

Resistance mutations of hepatitis B virus in entecavir‐refractory patients
por: Yamada, Norie, et al.
Publicado: (2017)

Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis
por: Yoshioka, Naoki, et al.
Publicado: (2020)

A Subclone of HuH-7 with Enhanced Intracellular Hepatitis C Virus Production and Evasion of Virus Related-Cell Cycle Arrest
por: Murayama, Asako, et al.
Publicado: (2012)

Effect of illness uncertainty on alanine transaminase levels and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease
por: Ozawa, Naoki, et al.
Publicado: (2022)

Critical Role of Interferon-α Constitutively Produced in Human Hepatocytes in Response to RNA Virus Infection
por: Tsugawa, Yoji, et al.
Publicado: (2014)

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
por: Matsunaga, Satoko, et al.
Publicado: (2020)

Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation
por: Nishitsuji, Hironori, et al.
Publicado: (2022)

Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression
por: Tasaka-Fujita, Megumi, et al.
Publicado: (2015)

Corrigendum: Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression
por: Tasaka-Fujita, Megumi, et al.
Publicado: (2015)

RNA Polymerase Activity and Specific RNA Structure Are Required for Efficient HCV Replication in Cultured Cells
por: Murayama, Asako, et al.
Publicado: (2010)

Liver stiffness measurement predicts hepatocellular carcinoma development in patients treated with direct‐acting antivirals
por: Tachi, Yoshihiko, et al.
Publicado: (2017)

Orchestration of Intracellular Circuits by G Protein-Coupled Receptor 39 for Hepatitis B Virus Proliferation
por: Goto, Kaku, et al.
Publicado: (2020)

High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon
por: Matsuda, Mami, et al.
Publicado: (2018)

Development of Mouse Hepatocyte Lines Permissive for Hepatitis C Virus (HCV)
por: Aly, Hussein Hassan, et al.
Publicado: (2011)

Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents
por: Nitta, Sayuri, et al.
Publicado: (2016)

Early Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma
por: Kuzuya, Teiji, et al.
Publicado: (2015)

Establishment of a novel hepatitis B virus culture system using immortalized human hepatocytes
por: Akahori, Yuichi, et al.
Publicado: (2020)

Production and Purification of Cell Culture–generated Hepatitis B Virus by Transient Transfection and Density Gradient
por: Murayama, Asako, et al.
Publicado: (2023)

Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma
por: Mizuno, Kazuyuki, et al.
Publicado: (2023)

Serodiagnostic Assay of Hepatitis C Virus Infection Using Viral Proteins Expressed in Escherichia coli
por: Mori, Shigehisa, et al.
Publicado: (1992)

Novel reporter system to monitor early stages of the hepatitis B virus life cycle
por: Nishitsuji, Hironori, et al.
Publicado: (2015)

Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B viruses
por: Nishitsuji, Hironori, et al.
Publicado: (2017)

Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis
por: Muto, Hisanori, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0g1o3o4a8824k7up58vi8scig8